I’m sure you’ve all heard about Ivermectin. It’s a safe anti-parasitic drug that has worked wonders in the African continent and has been in mass use around the world for over 30 years now. In the past two years of the pandemic, Ivermectin has saved innumerable lives of people infected with the novel Coronavirus and consequently suffering from Covid-19. The drug has proven to be effective in helping the human body fight a Covid-19 infection, and yet, the drug has not been approved by the Food and Drug Administration (FDA) of the United States of America.
The world knows that Ivermectin works against Covid-19, and the same has now been proven by a Japanese study. A Japanese conglomerate, Kowa Co. Ltd. has found that the anti-parasitic drug Ivermectin is effective and safe for the treatment of coronavirus’ Omicron variant, according to a phase III clinical trial.
The company, working with Kitasato University based in Tokyo, said that Ivermectin has the “same antiviral effect” on all “mutant strains,” including Alpha, Delta, and Omicron. Kowa added that ivermectin suppresses invasion of the virus and inhibits its replication. In its report, the Japanese conglomerate said, “[Ivermectin] is expected to be applied as a therapeutic drug (tablet) for all new coronavirus infectious diseases.”
As reported by TFIGlobal in November last year, Japan had said a loud and clear no to big pharma companies’ vaccination campaigns, with a small yet remarkable move. Japan decided to dump repeated vaccine doses for a better and more durable cure – one that was provided by Ivermectin.
Ivermectin has always shown good results and seemed to be on track for tackling the pandemic all by itself. However, big pharmaceutical companies, observing the success rate of the drug, decided to impose a ban on it, as it would have directly impacted their vaccination domination campaign. They also promoted and paid for brazen anti-Ivermectin propaganda.
Information security expert Ehden Biber had last year alleged, “If you were wondering why Ivermectin was suppressed, it is because the agreement that countries had with Pfizer does not allow them to escape their contract, which states that even if a drug will be found to treat COVID-19, the contract cannot be voided.”
It is undoubtedly true that Big Pharma has not behaved in an altruistic way after the outbreak of the COVID-19 pandemic. From the word go, it seemed that profit-making was considered more important than ending the pandemic itself. In the case of Ivermectin, the WHO was the first one to advise against its use for treating COVID-19. It stated, “The current evidence on the use of ivermectin to treat COVID-19 patients is inconclusive. Until more data is available, WHO recommends that the drug only be used within clinical trials.”
Two years into the pandemic, and the WHO – at the behest of Big Pharma, is still clueless about the usage of Ivermectin, while it continues to sanction additional booster doses of vaccines produced by Pfizer and Moderna without blinking an eye. That really tells you the story of how seriously WHO and the FDA/CDC take ‘data’.
A lot, amidst the ongoing pandemic, is riding on Big Pharma companies’ ability to keep selling more and more vaccines. A permanent cure for COVID-19 could have ended the need for multiple booster vaccine shots, which is why Ivermectin is not being allowed for usage in the United States and some other countries. India – with a population of 1.3 billion people has allowed the usage of Ivermectin and the drug is clouded by no controversy in the country, which is why India’s Covid-19 situation is far better than that of the U.S.
In September last year, Japan deployed Ivermectin and legalised the use of the anti-parasitic drug, which helped people recover from COVID-19 with more durable and long-lasting immunity. Caseloads have come down rapidly without the need for booster vaccination doses. Ivermectin use is thus helping Japan permanently beat the COVID-19 pandemic. And the same should teach anti-Ivermectin countries of the world a big lesson.